West Pharmaceutical Services Inc. (WST) News
Filter WST News Items
WST News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
WST News Highlights
- For WST, its 30 day story count is now at 5.
- Over the past 26 days, the trend for WST's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- DRUG, HSIC and MMSI are the most mentioned tickers in articles about WST.
Latest WST News From Around the Web
Below are the latest news stories about WEST PHARMACEUTICAL SERVICES INC that investors may wish to consider to help them evaluate WST as an investment opportunity.
13 Best Monthly Dividend Stocks to Buy According to AnalystsIn this article, we discuss 13 best monthly dividend stocks to buy according to analysts. You can skip our detailed analysis of dividend stocks and their performance, and go directly to read 5 Best Monthly Dividend Stocks to Buy According to Analysts. In 2022, dividends remained a bright spot for investors, despite a stock market […] |
HSIC or WST: Which Is the Better Value Stock Right Now?HSIC vs. WST: Which Stock Is the Better Value Option? |
West Announces Second-Quarter 2023 DividendWest Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announces that the Company's Board of Directors has approved a second-quarter 2023 dividend of $0.19 per share. The dividend will be paid on May 3, 2023, to shareholders of record as of April 26, 2023. |
MMSI vs. WST: Which Stock Is the Better Value Option?MMSI vs. WST: Which Stock Is the Better Value Option? |
Does West Pharmaceutical Services (WST) Have a Long Runway for Growth?Baron Funds, an investment management company, released its “Baron Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund gained 11.93% (Institutional Shares) compared to a 4.13% return for the Russell 2000 Growth Index and a 7.56% return for the S&P 500 Index. Favourable […] |
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2022 Earnings Call TranscriptWest Pharmaceutical Services, Inc. (NYSE:WST) Q4 2022 Earnings Call Transcript February 16, 2023 Operator: Good day, and thank you for standing by. Welcome to West Pharmaceutical Services Fourth Quarter 2022 Earnings Conference Call. . I would now like to hand the conference over to your speaker today, Quintin Lai, Vice President, Investor Relations. Please go […] |
West Pharmaceutical Services Full Year 2022 Earnings: Revenues Beat Expectations, EPS LagsWest Pharmaceutical Services ( NYSE:WST ) Full Year 2022 Results Key Financial Results Revenue: US$2.89b (up 2.0% from... |
Analyst Views West Pharmaceutical's Q4 Earnings Impressive Despite HeadwindsWest Pharmaceutical Services Inc (NYSE: WST) reported Q4 2022 net sales of $708.7 million, down 3%, and organic net sales growth was 2.6%, beating the consensus of $657.17 million. Q4 adjusted EPS of $1.77 fell 13.2% but beat the consensus of $1.38. COVID revenue was approximately $86 million for the quarter, and it now expects COVID contributions of $85 million for the next year as part of its 2023 guidance. EPS guidance of $7.25-$7.40 for 2023 was ahead of the Street ($7.27) and far better tha |
West Pharmaceutical (WST) Q4 Earnings Beat, Order Book StrongWest Pharmaceutical's (WST) fourth-quarter results reflect sustained growth in non-COVID-19 demand amid dismal overall performance. |
West Pharmaceutical Services (WST) Q4 Earnings and Revenues Beat EstimatesWest Pharmaceutical (WST) delivered earnings and revenue surprises of 27.34% and 8.16%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? |